pregnenolone has been researched along with sb 203580 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andreis, PG; Conconi, MT; Malendowicz, LK; Neri, G; Nussdorfer, GG; Parnigotto, PP; Petrelli, L; Rucinski, M | 1 |
1 other study(ies) available for pregnenolone and sb 203580
Article | Year |
---|---|
Neuropeptides B and W enhance the growth of human adrenocortical carcinoma-derived NCI-H295 cells by exerting MAPK p42/p44-mediated proliferogenic and antiapoptotic effects.
Topics: Adrenocortical Carcinoma; Apoptosis; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Golgi Apparatus; Humans; Hydrocortisone; Imidazoles; Mitochondria; Mitogen-Activated Protein Kinase 3; Neuropeptides; Pregnenolone; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; RNA, Messenger | 2005 |